PHARMACY

Slayback Pharma intros generic Makena
Slayback’s generic Makena also is the first generic of Amag Pharmaceuticals’ drug in a multidose vial.
Aurobindo to acquire Spectrum’s oncology injectables portfolio
Aurobindo is entering the branded oncology injectable space via an acquisition from Spectrum Pharmaceuticals.

HRG’s Rx Track-and-Trace tool targets DSCSA compliance

Hamacher's Rx Track-and-Trace Compliance Services include multiple components to help pharmacies meet Drug Supply Chain Security Act requirements.
FDA approves Lupin’s generic Synthroid tablets

The drug had a market size of roughly $2.5 billion for the 12 months ended September 2018, according to IQVIA data.
FDA approves Ontruzant, Samsung Bioepis’ Herceptin biosimilar

Samsung Bioepis has received its first approval for an oncology drug from the Food and Drug Administration, which has given the green light to the company's Ontruzant — a biosimilar of Herceptin.
PhRMA adds Genentech, Gilead Sciences to membership roster

With the addition of the two members, the Pharmaceutical Research and Manufacturers of America's membership now comprises the top 20 biopharmaceutical companies.
FDA chief: Agency has money for about 5 more weeks of drug approvals

FDA commissioner Scott Gottlieb responded to queries about the government shutdown's effect on drug approvals on Twitter.
FDA approves new Cabometyx indication

FDA's approval of a new Cabometyx indication provides a treatment for patients with liver cancer.
Walmart will remain in certain CVS Caremark Rx networks

Walmart will continue to participate in CVS Caremark's PBM commercial and Managed Medicaid retail pharmacy networks, as well as Medicare Part D networks.
Albertsons to use PQS's EQuIPP Analytics

Albertsons has chosen Pharmacy Quality Solutions' EQuIPP Analytics for enhanced reporting capabilities.